TY - JOUR T1 - The Use of Retinoids in Ovarian Cancer: A Review of the Literature JF - International Journal of Gynecologic Cancer JO - Int J Gynecol Cancer SP - 191 LP - 198 DO - 10.1097/IGC.0b013e318236a2ec VL - 22 IS - 2 AU - Jenny M. Whitworth AU - J. Michael Straughn AU - Venkatram R. Atigadda AU - Donald D. Muccio AU - Donald J. Buchsbaum Y1 - 2012/02/01 UR - http://ijgc.bmj.com/content/22/2/191.abstract N2 - Abstract Ovarian cancer is the deadliest of all gynecologic malignancies. The search for novel treatment modalities to augment traditional chemotherapy and improve quality of life is ongoing. Retinoids, a class of compounds composed of vitamin A, its natural derivatives, and synthetic analogs, have been studied extensively in both the prevention and treatment of gynecologic malignancies. In this article, we reviewed preclinical studies and clinical trials conducted using retinoids in ovarian cancer. ER -